United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-1128_e75d99fb-9d40-4f74-94d6-0e9b5e7a521b
- Product NDC
- 50090-1128
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100412
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (50090-1128-0) / 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 50090-1128-0
- 1 BLISTER PACK in 1 CARTON (50090-1128-1) / 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 50090-1128-1
- 1 BLISTER PACK in 1 CARTON (50090-1128-2) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 50090-1128-2
- 2 BLISTER PACK in 1 CARTON (50090-1128-3) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 50090-1128-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →